How did CTSO's revenue and expenses trend in Q4 2024?
4/14/2025 06:35pm
Cytosorbents (CTSO) experienced a revenue of $6.52 million in Q4 2024, reflecting a notable financial performance for the period. However, specific expense data for the quarter was not provided, making it challenging to analyze the company's profitability in detail. The absence of expense information prevents a comprehensive assessment of CTSO's financial health during this quarter.